Literature DB >> 5866717

The metabolism of thalidomide: some biological effects of thalidomide and its metabolites.

S Fabro, H Schumacher, R L Smith, R B Stagg, R T Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5866717      PMCID: PMC1510743          DOI: 10.1111/j.1476-5381.1965.tb02055.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  9 in total

1.  IDENTIFICATION OF THALIDOMIDE IN RABBIT BLASTOCYSTS.

Authors:  S FABRO; H SCHUMACHER; R L SMITH; R T WILLIAMS
Journal:  Nature       Date:  1964-03-14       Impact factor: 49.962

2.  [TOXIC AND TERATOGENIC EFFECTS OF THALIDOMIDE ON A RABBIT FETUS].

Authors:  D FELISATI; R NODARI
Journal:  Schweiz Med Wochenschr       Date:  1963-11-02

3.  Phthaloylisoglutamine, a metabolite of thalidomide.

Authors:  R L SMITH; R A WILLIAMS; R T WILLIAMS
Journal:  Life Sci (1962)       Date:  1962-07

4.  Thalidomide and congenital abnormalities.

Authors:  G S SOMERS
Journal:  Lancet       Date:  1962-04-28       Impact factor: 79.321

5.  The roles of amino acids in animal embryogenesis.

Authors:  E M DEUCHAR
Journal:  Biol Rev Camb Philos Soc       Date:  1962-08

6.  L-glutamic acid dehydrogenase; structural requirements for substrate competition; effect of thyroxine.

Authors:  W S CAUGHEY; L HELLERMAN; J D SMILEY
Journal:  J Biol Chem       Date:  1957-01       Impact factor: 5.157

7.  Metabolism of glutamine.

Authors:  A MEISTER
Journal:  Physiol Rev       Date:  1956-01       Impact factor: 37.312

8.  Studies on the enzymic synthesis of glutamine.

Authors:  W H ELLIOTT
Journal:  Biochem J       Date:  1951-06       Impact factor: 3.857

9.  The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.

Authors:  H Schumacher; R L Smith; R T Williams
Journal:  Br J Pharmacol Chemother       Date:  1965-10
  9 in total
  10 in total

1.  Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.

Authors:  John Caldwell
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 2.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

Authors:  Uwe Marx; Tommy B Andersson; Anthony Bahinski; Mario Beilmann; Sonja Beken; Flemming R Cassee; Murat Cirit; Mardas Daneshian; Susan Fitzpatrick; Olivier Frey; Claudia Gaertner; Christoph Giese; Linda Griffith; Thomas Hartung; Minne B Heringa; Julia Hoeng; Wim H de Jong; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Andreas Luch; Ilka Maschmeyer; Dmitry Sakharov; Adrienne J A M Sips; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Tewes Tralau; Sergej Tsyb; Anja van de Stolpe; Rob Vandebriel; Paul Vulto; Jufeng Wang; Joachim Wiest; Marleen Rodenburg; Adrian Roth
Journal:  ALTEX       Date:  2016-05-15       Impact factor: 6.043

3.  [What is the relevance of various previous lesions of the peripheral nervous system to a thalidomide polyneuropathy?].

Authors:  G P Liebaldt; F Broser
Journal:  Z Neurol       Date:  1971

4.  Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

Authors:  P M Fullerton; D J O'Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

5.  A double-blind study of the sedative effects of the thalidomide enantiomers in humans.

Authors:  P Höglund; T Eriksson; S Björkman
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

Review 6.  Thalidomide-type teratogenicity: structure-activity relationships for congeners.

Authors:  R L Smith; S C Mitchell
Journal:  Toxicol Res (Camb)       Date:  2018-09-26       Impact factor: 3.524

7.  The fate of[14C]thalidomide in the pregnant rabbit.

Authors:  S Fabro; R L Smith; R T Williams
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

8.  The fate of the hydrolysis products of thalidomide in the pregnant rabbit.

Authors:  S Fabro; R L Smith; R T Williams
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

Review 9.  Thalidomide: an antineoplastic agent.

Authors:  Robert J Amato
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.945

10.  Structural basis of thalidomide enantiomer binding to cereblon.

Authors:  Tomoyuki Mori; Takumi Ito; Shujie Liu; Hideki Ando; Satoshi Sakamoto; Yuki Yamaguchi; Etsuko Tokunaga; Norio Shibata; Hiroshi Handa; Toshio Hakoshima
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.